BioSpace News Archive

Scilex Holding Company, a nearly 100% majority-owned subsidiary of Sorrento Therapeutics, Inc., a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, announced ZTlido is now covered by managed health care plans representing approximately 190 million of the over 300 million covered lives across the United States.

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), today announced that it received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) regarding the company’s Biologics License Application (BLA) for pegzilarginase for the treatment of Arginase 1 Deficiency (ARG1-D).

Freenome, a privately held biotech company, announced three executives have joined the company to support its continued growth.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.

GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced a broad strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize companion diagnostic (CDx) assays for use with AstraZeneca’s therapies.

Kiyatec, a leader in functional precision oncology, announced new clinical evidence of its proprietary ex vivo 3D cell culture technology use in high-grade glioma will be presented at ASCO 2022.

According to QY Research Medical, the breast biopsy market was accounted at $658.17 million in 2020, and is estimated to reach US$ 1,082.44 million by 2030, growing at a CAGR of 5.5% from 2021 to 2030.

According to QY Research Medical, the digital pathology market was reached at $735.75 million in 2020, and it is expected to hit $1791.30 million by 2030, registering a CAGR of 9.6% from 2021 to 2030.

A study that includes researchers at Hospital for Special Surgery (HSS) underscores the importance of a multidisciplinary medical team to counsel and provide care for women with systemic lupus erythematosus, the most common form of lupus, who become pregnant.

Sysmex Inostics, Inc. and QIAGEN N.V. will co-exhibit at the 2022 ASCO Annual Meeting, the world’s largest clinical cancer research meeting, held June 3, 2022, through June 7, 2022, in Chicago.